iBio, Inc.IBIONYSE
Loading
Operating cash flow minus capital expenditures
Latest
$-19.19M
↑ 16% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
$-22.86M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-19.19M | -25.3% |
| 2025 | $-15.32M | +18.4% |
| 2024 | $-18.76M | +48.1% |
| 2023 | $-36.17M | +19.8% |
| 2022 | $-45.13M | -28.1% |
| 2021 | $-35.23M | -143.0% |
| 2020 | $-14.50M | +3.1% |
| 2019 | $-14.96M | -2.8% |
| 2018 | $-14.56M | +1.3% |
| 2017 | $-14.76M | - |